Live from the NIH registry
Studies recruiting near Chandler right now
Top 25 of 1,357 recruiting studies, sorted by proximity — each links to its official registry page
Shared Decision Making to Improve Goals of Care in the ED
Goals
N/A
Interventional 230 participants sought
Mayo Clinic in Arizona — Scottsdale, Arizona (15.9 mi)
· Sponsor: Mayo Clinic
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Phoenix Childrens Hospital — Phoenix, Arizona (17.2 mi)
· Sponsor: National Cancer Institute (NCI)
Acceptance and Commitment Therapy and Compassion-Based Virtual Group Therapy to Improve Psychological Wellbeing in Patients With Cancer
Hematopoietic and Lymphoid System Neoplasm, Malignant Solid Neoplasm
N/A
Interventional 200 participants sought
Mayo Clinic in Arizona — Scottsdale, Arizona (15.9 mi)
· Sponsor: Mayo Clinic
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
Lymphoma, Large B-Cell, Diffuse
Phase 2
Interventional 594 participants sought
Ironwood Cancer & Research Centers ( Site 0204) — Chandler, Arizona (1.7 mi)
· Sponsor: Merck Sharp & Dohme LLC
Study of TX000045 in Participants With Pulmonary Hypertension Due to Interstitial Lung Disease
Hypertension, Pulmonary, Lung Diseases, Interstitial
Phase 2
Interventional 25 participants sought
Phoenix — Phoenix, Arizona (17.2 mi)
· Sponsor: Tectonic Operating Company, Inc.
A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated
Diabetic Macular Edema
Phase 1, Phase 2
Interventional 49 participants sought
Research Network Arizona — Scottsdale, Arizona (15.9 mi)
· Sponsor: Boehringer Ingelheim
KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used With Investigational Agents in Treatment-naïve Participants With Stage IV Non-small Cell Lung Cancer (NSCLC) (MK-3475-01A/KEYMAKER-U01A)
Carcinoma, Non-Small-Cell Lung
Phase 1, Phase 2
Interventional 450 participants sought
Banner MD Anderson Cancer Center ( Site 0001) — Gilbert, Arizona (6.0 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study to Investigate the Safety and Efficacy of SAR446523 Injected Subcutaneously in Adult Participants With Relapsed/Refractory Myeloma
Plasma Cell Myeloma Refractory
Phase 1
Interventional 87 participants sought
Mayo Clinic in Arizona - Phoenix- Site Number : 8400005 — Phoenix, Arizona (17.2 mi)
· Sponsor: Sanofi
Juveena Hydrogel System Feasibility Study for Heavy Menstrual Bleeding (HMB)
Heavy Menstrual Bleeding
N/A
Interventional 7 participants sought
Arizona Gynecology Consultants — Phoenix, Arizona (17.2 mi)
· Sponsor: Rejoni Inc.
ELEVATE High-Risk PCI Pivotal Study
High-Risk Percutaneous Coronary Intervention (High-risk PCI)
N/A
Interventional 290 participants sought
HonorHealth Scottsdale Shea Medical Center/HonorHealth Deer Valley Medical Center — Scottsdale, Arizona (15.9 mi)
· Sponsor: Magenta Medical Ltd.
Transcatheter Tricuspid Valve Replacement With the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in Severe Tricuspid Regurgitation
Severe Tricuspid Regurgitation
N/A
Interventional 1,186 participants sought
Abrazo Arizona Heart Hospital — Phoenix, Arizona (17.2 mi)
· Sponsor: Medtronic Cardiovascular
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Bladder Carcinoma, Ureter Carcinoma
N/A
Observational 2,020 participants sought
Ironwood Cancer & Research Centers — Chandler, Arizona (1.7 mi)
· Sponsor: Guardant Health, Inc.
Addressing Disparities in Colorectal Cancer Screening in Black and Underserved Phoenix Communities
Colorectal Carcinoma
N/A
Interventional 450 participants sought
Mayo Clinic in Arizona — Scottsdale, Arizona (15.9 mi)
· Sponsor: Mayo Clinic
A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer
Advanced Prostate Cancer, Metastatic Prostate Cancer
Phase 1
Interventional 210 participants sought
HonorHealth — Scottsdale, Arizona (15.9 mi)
· Sponsor: Genentech, Inc.
A Multicenter Multinational Observational Study of Children With Hypochondroplasia
Hypochondroplasia
N/A
Observational 400 participants sought
Phoenix Children's Hospital — Phoenix, Arizona (17.2 mi)
· Sponsor: BioMarin Pharmaceutical
Observational Study Protocol: LIVER-R
Hepatobiliary Cancers
N/A
Observational 4,000 participants sought
Research Site — Phoenix, Arizona (17.2 mi)
· Sponsor: AstraZeneca
A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
Multiple Myeloma, Relapsed/Refractory Multiple Myeloma
Phase 2
Interventional 100 participants sought
HonorHealth — Scottsdale, Arizona (15.9 mi)
· Sponsor: C4 Therapeutics, Inc.
A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies
Solid Tumors
Phase 2
Interventional 170 participants sought
Local Institution - 0005 — Phoenix, Arizona (17.2 mi)
· Sponsor: Mirati Therapeutics Inc.
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Cancer Center at Saint Joseph's — Phoenix, Arizona (17.2 mi)
· Sponsor: SWOG Cancer Research Network
American Indian Chronic Renal Insufficiency Cohort Study (AI-CRIC Study)
Diabetes Mellitus, Chronic Kidney Diseases
N/A
Observational 500 participants sought
NIDDK-Phoenix Epidemiology and Clinical Research — Phoenix, Arizona (17.2 mi)
· Sponsor: University of New Mexico
MMA Embolization for Refractory Chronic Migraine
Migraine Disorders
N/A
Interventional 70 participants sought
Barrow Neurological Institute at St. Joseph's Hospital — Phoenix, Arizona (17.2 mi)
· Sponsor: Cerenovus, Part of DePuy Synthes Products, Inc.
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University-Telemedicine — Phoenix, Arizona (17.2 mi)
· Sponsor: Sameek Roychowdhury
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
PIK3CA Mutation, HER2- Negative Breast Cancer
Phase 3
Interventional 540 participants sought
Banner MD Anderson Cancer Center — Gilbert, Arizona (6.0 mi)
· Sponsor: Relay Therapeutics, Inc.
IGNITE: Study of Tirabrutinib vs Rituximab/Temozolomide for Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL)
Relapsed/Refractory Primary Central Nervous System Lymphoma
Phase 3
Interventional 132 participants sought
HonorHealth Cancer Center — Scottsdale, Arizona (15.9 mi)
· Sponsor: Ono Pharmaceutical Co., Ltd.
Light Exposure, Migraine Outcomes, and Sleep Quality
Migraine Headache, Sleep
N/A
Interventional 20 participants sought
ASU DeSmart Lab — Tempe, Arizona (9.7 mi)
· Sponsor: Arizona State University